EUVIMEDEUVIMED entdecken
Crossref

Notoginsenoside R 1 decreases intraplaque neovascularization by governing pericyte‐endothelial cell communication via Ang1/Tie2 axis in atherosclerosis

Yuan Li iD, Lei Zhang iD, Wenqing Yang iD, Lin Lin iD, Jinyuan Pan iD, Mengkai Lu iD, Zhiyuan Zhang iD, Yunlun Li iD, Chao Li iD

Phytotherapy Research · 2024-08 · 38 (8) · 4036-4052

DOI: 10.1002/ptr.8257 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Phytotherapy Research, online erschienen am 17.06.2024. Verfasst von Yuan Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: First Clinical Medical College, Shandong University of Traditional Chinese Medicine, Jinan, China. Hauptthemen laut MEDLINE: Ginsenosides, Pericytes, Atherosclerosis, Plaque, Atherosclerotic. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 73 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Young Talent of Lifting Engineering for Science and Technology in Shandong, the Outstanding Youth Innovation Team of Shandong Institutions of Higher Learning.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Atherosclerosis represents the major cause of mortality worldwide and triggers higher risk of acute cardiovascular events. Pericytes‐endothelial cells (ECs) communication is orchestrated by ligand‐receptor interaction generating a microenvironment which results in intraplaque neovascularization, that is closely associated with atherosclerotic plaque instability. Notoginsenoside R 1 ( R 1 ) exhibits anti‐atherosclerotic bioactivity, but its effect on angiogenesis in atherosclerotic plaque remains elusive. The aim of our study is to explore the therapeutic effect of R 1 on vulnerable plaque and investigate its potential mechanism against intraplaque neovascularization. The impacts of R 1 on plaque stability and intraplaque neovascularization were assessed in ApoE −/− mice induced by high‐fat diet. Pericytes‐ECs direct or non‐direct contact co‐cultured with VEGF‐A stimulation were used as the in vitro angiogenesis models. Overexpressing Ang1 in pericytes was performed to investigate the underlying mechanism. In vivo experiments, R 1 treatment reversed atherosclerotic plaque vulnerability and decreased the presence of neovessels in ApoE −/− mice. Additionally, R 1 reduced the expression of Ang1 in pericytes. In vitro experiments demonstrated that R 1 suppressed pro‐angiogenic behavior of ECs induced by pericytes cultured with VEGF‐A. Mechanistic studies revealed that the anti‐angiogenic effect of R 1 was dependent on the inhibition of Ang1 and Tie2 expression, as the effects were partially reversed after Ang1 overexpressing in pericytes. Our study demonstrated that R 1 treatment inhibited intraplaque neovascularization by governing pericyte‐EC association via suppressing Ang1‐Tie2/PI3K‐AKT paracrine signaling pathway. R 1 represents a novel therapeutic strategy for atherosclerotic vulnerable plaques in clinical application.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GinsenosidesPericytesAtherosclerosisPlaque, AtheroscleroticReceptor, TIE-2Endothelial CellsNeovascularization, PathologicAngiopoietin-1AnimalsMiceMice, Inbred C57BLMaleCell CommunicationHumansSignal TransductionApolipoproteins EDiet, High-FatVascular Endothelial Growth Factor A

Stichwörter der Autor:innen

Ang1/Tie2angiogenesisatherosclerotic vulnerable plaquenotoginsenoside R1pericyte‐EC communication

Substanzen

Ginsenosidesnotoginsenoside R1Receptor, TIE-2Angiopoietin-1Apolipoproteins EAngpt1 protein, mouseVascular Endothelial Growth Factor A

Autor:innen und Institutionen

  • First Clinical Medical College, Shandong University of Traditional Chinese Medicine, Jinan, China.
  • Experimental Center, Shandong University of Traditional Chinese Medicine, Jinan, China.
  • College of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan, China.
  • Department of Cardiovascular, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, China.
  • Innovation Research Institute of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan, China.

ORCID-Profile: Yuan Li, Lei Zhang, Wenqing Yang, Lin Lin, Jinyuan Pan, Mengkai Lu, Zhiyuan Zhang, Yunlun Li, Chao Li

Förderung

  • National Natural Science Foundation of China
  • Young Talent of Lifting Engineering for Science and Technology in Shandong
  • the Outstanding Youth Innovation Team of Shandong Institutions of Higher Learning
  • "20 Measures for Colleges and Universities" Project of Jinan
  • Natural Science Foundation of Shandong Province

Zitieren

APA

Li, Y., Zhang, L., Yang, W., Lin, L., Pan, J., Lu, M., Zhang, Z., Li, Y., & Li, C. (2024). Notoginsenoside R 1 decreases intraplaque neovascularization by governing pericyte‐endothelial cell communication via Ang1/Tie2 axis in atherosclerosis. Phytotherapy Research, 38(8), 4036-4052. https://doi.org/10.1002/ptr.8257

Vancouver

Li Y, Zhang L, Yang W, Lin L, Pan J, Lu M, et al. Notoginsenoside R 1 decreases intraplaque neovascularization by governing pericyte‐endothelial cell communication via Ang1/Tie2 axis in atherosclerosis. Phytotherapy Research. 2024;38(8):4036-4052. doi:10.1002/ptr.8257

BibTeX
@article{Li2024,
  author = {Li, Yuan and Zhang, Lei and Yang, Wenqing and Lin, Lin and Pan, Jinyuan and Lu, Mengkai and Zhang, Zhiyuan and Li, Yunlun and Li, Chao},
  title = {Notoginsenoside R 1 decreases intraplaque neovascularization by governing pericyte‐endothelial cell communication via Ang1/Tie2 axis in atherosclerosis},
  journal = {Phytotherapy Research},
  year = {2024},
  volume = {38},
  number = {8},
  pages = {4036--4052},
  doi = {10.1002/ptr.8257}
}
Kostenlos starten →